Will glutathione lighten skin permanently
Supporting repair pathways can help you do the work
PMCID: PMC7108996 Andersen NB, Malmlf K, Johansen PB, Andreassen TT, rtoft G, Oxlund H
2025: Novo Nordisk announced positive Phase 3 ESSENCE trial results for semaglutide in early Alzheimer's disease, reporting statistically significant slowing of cognitive and functional decline a breakthrough data package that could establish GLP-1 therapy as a neuroprotective agent and open an addressable market of 6.5 million Alzheimer's patients in the U.S
You may have come across it in the context of medications like semaglutide (Ozempic or Wegovy), but GLP-1 isnt a drugits a hormone your body naturally produces
For research into complex hormone interactions, the added challenges may be worth it